OA
GILD icon

Operose Advisors’s Gilead Sciences GILD Stock Holding History

Operose Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Sell
800
-244
-23% -$32.1K 0.02% 241
2026
Q1 		$146K Buy
1,044
+244
+31% +$34.2K 0.03% 176
2025
Q4 		$98.2K Hold
800
– – 0.02% 217
2025
Q3 		$88.8K Hold
800
– – 0.02% 209
2025
Q2 		$88.7K Hold
800
– – 0.03% 190
2025
Q1 		$89.6K Hold
800
– – 0.03% 177
2024
Q4 		$73.9K Sell
800
-1,204
-60% -$108K 0.03% 189
2024
Q3 		$168K Buy
2,004
+289
+17% +$22.1K 0.05% 156
2024
Q2 		$118K Hold
1,715
– – 0.04% 176
2024
Q1 		$126K Hold
1,715
– – 0.04% 183
2023
Q4 		$139K Sell
1,715
-720
-30% -$56K 0.06% 135
2023
Q3 		$182K Buy
2,435
+1,348
+124% +$104K 0.07% 142
2023
Q2 		$83.8K Hold
1,087
– – 0.04% 136
2023
Q1 		$90.2K Sell
1,087
-438
-29% -$36.3K 0.04% 121
2022
Q4 		$131K Buy
1,525
+688
+82% +$54.5K 0.07% 95
2022
Q3 		$52K Buy
837
+587
+235% +$37K 0.03% 144
2022
Q2 		$15K Hold
250
– – 0.01% 217
2022
Q1 		$15K Buy
+250
New +$16K 0.01% 233

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Operose Advisors's GILD Position: Q2 2026 in Review

Operose Advisors reduced its Gilead Sciences (GILD) stake by 23% in Q2 2026, selling an estimated $32.1K and leaving 800 shares worth $101K. The position accounts for 0.02% of the portfolio, ranked #241.

Operose Advisors first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $182K in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Operose Advisors held 800 shares of Gilead Sciences worth $101K as of Q2 2026.
  • Operose Advisors sold 244 Gilead Sciences shares in Q2 2026, an estimated $32.1K.
  • Gilead Sciences made up 0.02% of Operose Advisors's portfolio in Q2 2026, its #241 holding.
  • Operose Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Operose Advisors's Gilead Sciences position peaked at $182K in Q3 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.